WallStreetZenWallStreetZen

NASDAQ: BRTX
Biorestorative Therapies Inc Stock

Open Broker Account
$3.02+0.09 (+3.07%)
Updated Dec 8, 2022
BRTX Price
$3.02
Fair Value Price
$20.82
Market Cap
$11.09M
52 Week Low
$2.46
52 Week High
$6.25
P/E
-0.28x
P/B
0.65x
P/S
97.15x
PEG
N/A
Dividend Yield
N/A
Revenue
$121.10k
Earnings
-$34.55M
Gross Margin
100%
Operating Margin
-28,267.61%
Profit Margin
-28,530.4%
Debt to Equity
0.05
Operating Cash Flow
-$5M
Beta
-0.38
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

BRTX Overview

BioRestorative Therapies Inc is a biotechnology company developing therapies using cell and tissue protocols, mostly involving non-embryonic stem cells. The company's Disc/Spine Program includesBRTX-100, a cell therapy candidate formulated from stem cells collected from the patient's bone marrow. Its Metabolic Program is developing a cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells. BioRestorative Therapies was founded in 1997 and is headquartered in Melville, New York.

Zen Score

Industry Average (29)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how BRTX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

BRTX ($3.02) is undervalued by 85.5% relative to our estimate of its Fair Value price of $20.82 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
BRTX ($3.02) is significantly undervalued by 85.5% relative to our estimate of its Fair Value price of $20.82 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
BRTX is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more BRTX due diligence checks available for Premium users.

Be the first to know about important BRTX news, forecast changes, insider trades & much more!

BRTX News

Valuation

BRTX fair value

Fair Value of BRTX stock based on Discounted Cash Flow (DCF)
Price
$3.02
Fair Value
$20.82
Undervalued by
85.50%
BRTX ($3.02) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
BRTX ($3.02) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
BRTX is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

BRTX price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.28x
Industry
13.31x
Market
21.39x

BRTX price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.65x
Industry
4.98x
BRTX is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

BRTX's financial health

Profit margin

Revenue
$29.0k
Net Income
-$4.7M
Profit Margin
-16,054.6%
BRTX's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
BRTX's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$17.9M
Liabilities
$915.9k
Debt to equity
0.05
BRTX's short-term assets ($16.89M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
BRTX's short-term assets ($16.89M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
BRTX's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
BRTX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$1.5M
Investing
-$9.9M
Financing
$0.0
BRTX's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

BRTX vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
BRTX$11.09M+3.07%-0.28x0.65x
XRTX$11.11M-2.84%2.25x1.42x
UNCY$11.00M+0.28%-0.71x2.38x
ONCR$10.96M+7.93%-0.14x0.14x
NRBO$11.25M+25.36%-0.11x1.89x

Biorestorative Therapies Stock FAQ

What is Biorestorative Therapies's quote symbol?

NASDAQ: BRTX) Biorestorative Therapies trades on the NASDAQ under the ticker symbol BRTX. Biorestorative Therapies stock quotes can also be displayed as NASDAQ: BRTX.

If you're new to stock investing, here's how to buy Biorestorative Therapies stock.

What is the 52 week high and low for Biorestorative Therapies (NASDAQ: BRTX)?

(NASDAQ: BRTX) Biorestorative Therapies's 52-week high was $6.25, and its 52-week low was $2.46. It is currently -51.68% from its 52-week high and 22.76% from its 52-week low.

How much is Biorestorative Therapies stock worth today?

(NASDAQ: BRTX) Biorestorative Therapies currently has 3,673,629 outstanding shares. With Biorestorative Therapies stock trading at $3.02 per share, the total value of Biorestorative Therapies stock (market capitalization) is $11.09M.

Biorestorative Therapies stock was originally listed at a price of $32.00 in Dec 5, 2012. If you had invested in Biorestorative Therapies stock at $32.00, your return over the last 10 years would have been -90.56%, for an annualized return of -21.03% (not including any dividends or dividend reinvestments).

How much is Biorestorative Therapies's stock price per share?

(NASDAQ: BRTX) Biorestorative Therapies stock price per share is $3.02 today (as of Dec 8, 2022).

What is Biorestorative Therapies's Market Cap?

(NASDAQ: BRTX) Biorestorative Therapies's market cap is $11.09M, as of Dec 10, 2022.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Biorestorative Therapies's market cap is calculated by multiplying BRTX's current stock price of $3.02 by BRTX's total outstanding shares of 3,673,629.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.